Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-15 to 2023-02-16
Current total value of award: $2474.93
Description: 4559957442!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML